Prednisolone

Table of contents

  • Brand Names
  • Drug Combinations
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Genes that may be involved
  • Substrate of
  • Inhibits
  • Induces
  • Drug Interactions
  • Nutrition/Nutraceutical Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names

Europe

Austria: Aprednislon, Kuehlprednon, Prednisolon, Ultracortenol; Belgium: Pred Forte; Bulgaria: Prednisolon, Ultracortenol; Cyprus: Econopred; Czech Republic: Alpicort, Predni-Pos, Ultracortenol; Denmark: Prednisolon, Ultracortenol; Estonia: Prednisolon; Finland: Pred Forte, Prednisolon; France: Deturgylone, Hydrocortancyl; Germany: Decortin H, Dermosolon, Dontisolon, Hefasolon, Infectocortikrupp, Inflanefran, Klismacort, Linola H N, Lygal Kopftinktur, Pred Forte, Predni, Prednigalen, Prednisolon, Prednisolut, Ultracortenol; Greece: Adelcort, Conjunctilone, Corticort, Delta Cortef, Deltacortril, Oskibral, Prednisolone, Prezolon, Solupred, Ultracortenol; Hungary: Alpicort, Prednisolon; Ireland: Deltacortril, Predfoam, Prednesol, Prednisolone; Italy: Caberdelta, Cortisolone, Deltidrosol, Domucortone, Meticortelone, Predartrina; Lithuania: Prednisolon, Premandol; Luxembourg: Deltacortril, Prednicortelone, Prednisolone; Netherlands: Di-Adreson-F, Pred Forte, Prednisolon, Ultracortenol; Poland: Encortolon, Fenicort, Linola P, Mecortolon, Prednisolonum; Romania: Decortin H, Ultracortenol; Slovakia: Ultracortenol; Spain: Estilsona, Pred Forte; Sweden: Precortalon, Prednisolon, Ultracortenol; UK: Deltacortril, Deltastab, Pred Forte, Prednisolone, Predsol.

North America

Canada: Diopred, Pediapred, Pred Forte, Pred Mild, Prednisolone; USA: Flo-Pred, Omnipred, Orapred, Pediapred, Pred Forte, Pred Mild, Prednisolone, Prelone.

Latin America

Argentina: Ultracortenol; Brazil: Oftpred, Oralpred, Pred Fort, Pred Mild, Prednisolon, Prednisolona, Predsim, Prelone; Mexico: Delta Corti Ofteno, Delta-Diona, Desnisol, Fisopred, Meticortelone, Pred, Prednefrín, Prednisolona, Sophipren Ofteno.

Asia

Japan: Bisuo, Farnerate, Farnezone, Kohakusanin, Lidomex, Predohan, Predonema, Predonine, Predonisolone, Roapesin, Spirazon, Youmeton.

Drug combinations

Prednisolone and Chloramphenicol

Prednisolone and Estradiol

Prednisolone and Gentamicin

Prednisolone and Lidocaine

Prednisolone and Naphazoline

Prednisolone and Neomycin

Prednisolone and Oxytetracycline

Prednisolone and Phenylephrine

Prednisolone and Quinoline

Prednisolone and Salicylic Acid

Prednisolone and Sodium Phosphate

Prednisolone and Sulfacetamide

Prednisolone, Bismuth, and Zinc Oxide

Prednisolone, Clotrimazole, and Hexamidine

Prednisolone, Dipyrone, and Polymyxin B

Prednisolone, Framycetin, and Naphazoline

Prednisolone, Miconazole, and Polymyxin B

Prednisolone, Neomycin, and Polymyxin B

Prednisolone, Neomycin, and Sulfacetamide

Prednisolone, Sodium Phosphate, and Sulfacetamide

Prednisolone, Cetrimide, Glycerin, and Propylene Glycol

Chemistry

Prednisolone: C~21~H~28~O~5~. Mw: 360.44. (1) Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11β)-; (2) 11β,17,21-Trihydroxypregna-1,4-diene-3,20-dione. CAS-50-24-8 (anhydrous); CAS-52438-85-4 (sesquihydrate).

Prednisolone Acetate: C~23~H~30~O~6~. Mw: 402.48. 11β,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-acetate. CAS-52-21-1.

Prednisolone Sodium Phosphate: C~21~H~27~Na~2~O~8~P. Mw: 484.39. 11β,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(disodium phosphate). CAS-125-02-0; CAS-302-25-0 (prednisolone 21-(dihydrogen phosphate)).

Pharmacologic Category

Hormones and Synthetic Substitutes; Adrenals. EENT Preparations; Anti-inflammatory Agents; Corticosteroids. Ophthalmic Corticosteroid. Systemic Corticosteroid. (ATC-Code: A07EA01; C05AA04; D07AA03; D07XA02; H02AB06; H02AB06; R01AD02; S01BA04; S01CB02; S02BA03; S03BA02).

Mechanism of action

Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability. Suppresses immune system by reducing activity and volume of lymphatic system.

Therapeutic use

Treatment of palpebral and bulbar conjunctivitis. Corneal injury from chemical, radiation, thermal burns, or foreign body penetration. Endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, and gastrointestinal diseases. Resolution of acute exacerbations of multiple sclerosis. Management of fulminating or disseminated tuberculosis and trichinosis. Acute or chronic solid organ rejection.

Pregnancy and lactiation implications

Ophthalmic prednisolone shown to be teratogenic in animal studies and adverse events observed with corticosteroids in animal reproduction studies. Prednisolone crosses placenta. Some studies have shown association between 1^st^ trimester corticosteroid use and oral clefts. Adverse events in fetus/neonate noted in case reports following large doses of systemic corticosteroids during pregnancy. Enters breast milk (use caution).

Unlabeled use

Contraindications

Hypersensitivity to prednisolone or any component of the formulation. Acute superficial herpes simplex keratitis. Live or attenuated virus vaccines (with immunosuppressive doses of corticosteroids). Systemic fungal infections. Varicella.

Warnings and precautions

May cause hypercorticism or suppression of hypothalamic-pituitary-adrenal axis, particularly in younger children or in patients receiving high doses for prolonged periods, which may lead to adrenal crisis. Prolonged use of corticosteroids may also increase incidence of secondary infection, mask acute infection (including fungal infections) or prolong or exacerbate viral infections. Exposure to chickenpox should be avoided. Corticosteroids should not be used to treat ocular herpes simplex, cerebral malaria or viral hepatitis. Use with caution in tuberculosis. Prolonged treatment with corticosteroids associated with development of Kaposi’s sarcoma (case reports). Acute myopathy reported with high dose corticosteroids, usually in neuromuscular transmission disorders (may involve ocular and/or respiratory muscles). Prolonged use of corticosteroids may result in glaucoma. Damage to optic nerve (not indicated for treatment of optic neuritis), defects in visual acuity and fields of vision, and posterior subcapsular cataract formation may occur. Use following cataract surgery may delay healing or increase incidence of bleb formation. Corticosteroid use may cause psychiatric disturbances, including depression, euphoria, insomnia, mood swings, and personality changes. Pre-existing psychiatric conditions may be exacerbated. Use with caution in heart failure (long-term use associated with fluid retention and hypertension), in diabetes mellitus (may alter glucose production/regulation leading to hyperglycemia), and in gastrointestinal diseases (diverticulitis, peptic ulcer, ulcerative colitis) due to perforation risk. Use with caution in hepatic impairment, including cirrhosis (long-term use associated with fluid retention), in myasthenia gravis (exacerbation of symptoms), following acute myocardial infarction (risk of myocardial rupture), and in osteoporosis (high doses and/or long-term use of corticosteroids associated with increased bone loss and osteoporotic fractures). Use with caution in renal impairment (fluid retention may occur), and in history of seizure disorder (seizures reported with adrenal crisis). Metabolic clearance of corticosteroids increases in hyperthyroidism and decreases in hypothyroidism. Due to risk of adverse effects, systemic corticosteroids should be used cautiously in the elderly. May affect growth velocity. Withdrawal of corticosteroids may result in salicylate toxicity.

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart